|
"lin chia chi"的相關文件
顯示項目 106-115 / 148 (共15頁)
<< < 6 7 8 9 10 11 12 13 14 15 > >>
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2008 |
Acute Encephalopathy Following Arsenic Trioxide for Metastatic Urothelial Carcinoma
|
林家齊; 蒲永孝; 徐志宏; 耿孝宜; 鄭安理; 楊志新; LIN, CHIA-CHI; PU, YEONG-SHIAU; HSU, CHIH-HUNG; KENG, HSIAO-YI; CHENG, ANN-LII; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2008 |
Association of Clinical and Dosimetric Factors with Postoperative Pulmonary Complication in Esophageal Cancer Patients Receiving Intensity Modulated Radiation Therapy Followed by Esophagectomy
|
許峰銘; 吳簡坤; 李元麒; 李章銘; 林家齊; 徐志宏; 蔡育傑; 成佳憲; HSU, FENG-MING; WU, JIAN-KUEN; LEE, YUNG-CHIE; LEE, JANG-MING; LIN, CHIA-CHI; HSU, CHIH-HUNG; TSAI, YU-CHIEH; CHENG, JASON CHIA-HSIEN |
| 國立臺灣大學 |
2008 |
Atorvastatin Induces Thrombomodulin Expression in the Aorta of Cholesterol -Fed Rabbits and in Tnf Alpha-Treated Human Aortic Endothelial Cells
|
林幸榮; 謝芳瑜; 陳永祥; 林家齊; 管奕奕; 王淑慧; 吳造中; 簡雄飛; 林豐彥; 陳玉怜; LIN, SHING-JONG; HSIEH, FANG-YU; CHEN, YUNG-HSIANG; LIN, CHIA-CHI; KUAN, I-I; WANG, SHU-HUEI; WU, CHAU-CHUNG; CHIEN, HSIUNG-FEI; LIN, FENG-YEN; CHEN, YUH-LIEN |
| 國立臺灣大學 |
2008 |
Gemcitabine Plus Conventional-Dose Epirubicin Versus Gemcitabine Plus Cisplatin as First-Line Chemotherapy for Stage Iiib/Iv Non-Small Cell Lung Carcinoma-a Randomized Phase Ii Trial
|
許駿; 郭頌鑫; 胡賦强; 鄭安理; 施金元; 余忠仁; 林家齊; 楊泮池; 楊志新; HSU, CHIUN; KUO, SUNG-HSIN; HU, FU-CHANG; CHENG, ANN-LII; SHIH, JIN-YUAN; YU, CHONG-JEN; LIN, CHIA-CHI; YANG, PAN-CHYR; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2008 |
Improved Local Control by Surgery and Paclitaxel-Based Chemoradiation for Esophageal Squamous Cell Carcinoma: Results of a Retrospective Non- Randomized Study
|
許峰銘; 林家齊; 李章銘; 張逸良; 徐志宏; 蔡育傑; 李元麒; 成佳憲; HSU, FENG-MING; LIN, CHIA-CHI; LEE, JANG-MING; CHANG, YIH-LEONG; HSU, CHIH-HUNG; TSAI, YU-CHIEH; LEE, YUNG-CHIE; CHENG, JASON CHIA-HSIEN |
| 國立臺灣大學 |
2008 |
Systemic Therapy for Metastatic Urothelial Carcinoma
|
林家齊; 徐志宏; 蒲永孝; LIN, CHIA-CHI; HSU, CHIH-HUNG; PU, YEONG-SHIAU |
| 國立臺灣大學 |
2007-05 |
Weekly paclitaxel and high-dose 5-Fluorouracil plus leucovorin (T-HDFL) in hormone-refractory prostate cancer: in Vitro combined effects and phase II trial
|
Lin, Chia-Chi; Hsu, Chih-Hung; Hour, Tzyh-Chyuan; Cheng, Ann-Lii; Huang, Chao-Yuan; Huang, Kuo-How; Chen, Jun; Pu, Yeong-Shiau |
| 國立臺灣大學 |
2007-04 |
Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: a phase II study
|
Lin, Chia-Chi; Chih-Hung; Hsu; Huang, Chao-Yuan; Keng, Hsiao-Yi; Tsai, Yu-Chieh; Huang, Kuo-How; Cheng, Ann-Lii; Pu, Yeong-Shiau |
| 國立臺灣大學 |
2007-03 |
Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens
|
Lin, Chia-Chi; Hsu, Chih-Hung; Huang, Chao-Yuan; Tsai, Yu-Chieh; Huang, Kuo-How; Cheng, Ann-Lii; Pu, Yeong-Shiau |
| 國立臺灣大學 |
2007-01 |
Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High-Dose 5-Fluorouracil and Leucovorin (TP-HDFL) for Metastatic Urothelial Carcinoma
|
Lin, Chia-Chi; Hsu, Chih-Hung; Huang, Chao-Yuan; Cheng, Ann-Lii; Pu, Nicholas J. Vogelzang Yeong-Shiau |
顯示項目 106-115 / 148 (共15頁)
<< < 6 7 8 9 10 11 12 13 14 15 > >>
每頁顯示[10|25|50]項目
|
